CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 1,697.00
-4.20 (-0.25%)
At close: May 26, 2026
CORONA Remedies Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,851 | 1,494 | 905.03 | 849.29 | -4 |
Depreciation & Amortization | 378.7 | 368.61 | 279.84 | 199.04 | 202.82 |
Other Amortization | - | 2.99 | 2.94 | 1.99 | 2.02 |
Loss (Gain) From Sale of Assets | 5.4 | 7.05 | 12.05 | 0.2 | - |
Loss (Gain) From Sale of Investments | -0.7 | -0.2 | -2.56 | -2.46 | -1.01 |
Loss (Gain) on Equity Investments | - | -3.85 | -0.06 | -2.28 | - |
Provision & Write-off of Bad Debts | 2.3 | 0.53 | -1.32 | 2.21 | 0.65 |
Other Operating Activities | 116.6 | 206.1 | 278.51 | 28.16 | -20.02 |
Change in Accounts Receivable | -262.1 | -183.58 | -126.31 | -129.17 | 1,329 |
Change in Inventory | 52.1 | -333.87 | 64.71 | -314.54 | -433.47 |
Change in Accounts Payable | 37.1 | 294.2 | 201.16 | 98.28 | 125.56 |
Change in Other Net Operating Assets | 114.2 | 52.64 | -46.41 | 296.28 | -224.01 |
Operating Cash Flow | 2,295 | 1,905 | 1,568 | 1,027 | 977.05 |
Operating Cash Flow Growth | 20.46% | 21.52% | 52.64% | 5.11% | 23.42% |
Capital Expenditures | -1,741 | -916.48 | -2,863 | -947.58 | -340.07 |
Sale of Property, Plant & Equipment | 5.4 | 6.37 | 5.71 | 9.5 | - |
Investment in Securities | -896.1 | 27.53 | 144.61 | 375.88 | -404.07 |
Other Investing Activities | 70.6 | 44.18 | 46.65 | 59.75 | 86.34 |
Investing Cash Flow | -2,562 | -838.4 | -2,666 | -502.45 | -657.8 |
Short-Term Debt Issued | 1,162 | - | 288.11 | 2.64 | - |
Long-Term Debt Issued | - | - | 1,800 | - | - |
Total Debt Issued | 1,162 | - | 2,088 | 2.64 | - |
Short-Term Debt Repaid | - | -204.47 | - | - | -26.85 |
Long-Term Debt Repaid | -387.8 | -533.78 | -788.59 | -336.64 | -151.67 |
Total Debt Repaid | -387.8 | -738.25 | -788.59 | -336.64 | -178.52 |
Net Debt Issued (Repaid) | 773.8 | -738.25 | 1,300 | -334 | -178.52 |
Common Dividends Paid | -447.1 | -226.29 | -169.41 | -69.72 | -69.94 |
Other Financing Activities | -73.9 | -101.35 | -144.66 | -43.75 | -50.14 |
Financing Cash Flow | 252.8 | -1,066 | 985.45 | -447.47 | -298.6 |
Foreign Exchange Rate Adjustments | - | - | 0.02 | -0.38 | -0.3 |
Net Cash Flow | -13.9 | 0.67 | -113.38 | 76.7 | 20.35 |
Free Cash Flow | 553.4 | 988.48 | -1,296 | 79.42 | 636.98 |
Free Cash Flow Growth | -44.02% | - | - | -87.53% | 84.55% |
Free Cash Flow Margin | 3.94% | 8.26% | -12.77% | 0.90% | 10.32% |
Free Cash Flow Per Share | 9.05 | 16.16 | -21.19 | 1.36 | 12.48 |
Cash Interest Paid | 73.9 | 101.35 | 144.66 | 43.75 | 50.14 |
Cash Income Tax Paid | 494.2 | 432.76 | 179.05 | 258.22 | 14.99 |
Levered Free Cash Flow | 745.68 | 522.69 | -1,796 | -24.62 | -221.01 |
Unlevered Free Cash Flow | 789.24 | 587.43 | -1,709 | -0.07 | -192.59 |
Change in Working Capital | -58.7 | -170.61 | 93.15 | -49.15 | 796.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.